Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus. Werth VP, Furie RA, Romero-Diaz J, Navarra S, et al. N Engl J Med 2022;387:321-331.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Werth VP, Furie RA, Romero-Diaz J, Navarra S, et al. Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus. N Engl J Med 2022;387:321-331.
PMID: 35939578

Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016